Thomas Bachinski serves as Executive at NEUROONE MEDICAL TECHNOLOGIES Corp, where they oversee executive responsibilities. Since joining the company, Thomas Bachinski has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 20, 2017 involved receiving (via award) 215,453 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 20, 2017 | OSOK | $0 | Award | 215,453 | $N/A | Discretionary |
Thomas Bachinski currently holds 215,453 shares of NEUROONE MEDICAL TECHNOLOGIES Corp (OSOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Bachinski has been a net neutral trader of OSOK stock. They have purchased $0 and sold $0 worth of shares.
Thomas Bachinski's most recent insider trade was on Jul 20, 2017, when they sold 215,453 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted